Dr Crispin Hiley

Dr Crispin Hiley

Clinical oncology 06122217

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Breast
  • Colon
  • Gynaecology
  • Lower GI
  • Lung
  • Soft tissue
  • Urology


  • Face-to-face consultations
  • Video and telephone consultations

About me

Dr Hiley is an Associate Professor with tenure in Radiation Oncology at UCL and a Consultant Clinical Oncologist at UCLH. He is the UK clinical director for lung cancer at GenesisCare.

He specialises in stereotactic radiotherapy (SBRT) for all kinds of metastatic cancers e.g. breast, prostate, colorectal, lung, sarcoma etc.

Dr Hiley specialises in all the non-surgical treatments for all types of lung cancer. He has expertise in chemotherapy, immunotherapy and radiotherapy including state of the art radiotherapy techniques including Volumetric Arc Therapy (VMAT), Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Proton Therapy and Stereotactic Radiotherapy (SBRT).

He graduated with honours from the University in Manchester in 2005. He has trained in Oncology at many centres of excellence both in the UK and aboard. These include the Christie Hospital, the MD Anderson Cancer Centre (Houston, USA), Kings College (NIHR Clinical Lecturer) and the Royal Marsden (NIHR Clinical Fellow). He completed a PhD at the University of London with the Barts Cancer Institute and a postdoctoral research Fellowship the Francis Crick Institute and the UCL Cancer institute.

He became a consultant in 2018 and is clinical lead of the clinical oncology lung team at UCLH, UCLH Lead for Lung Proton Therapy, Deputy Lead of Clinical Trials for the CRUK Lung Cancer Centre of Excellence and NIHR Clinical Research Network Speciality Research Lead Radiotherapy for North London. He heads a research group at the UCL Cancer Institute focused on understanding resistance to radiation therapy.

He is the principal investigator and national chief investigator for several academic and commercial clinical trials in lung cancer. He has published in several the world’s leading journals including NEJM, The Lancet, Nature and Cell. He is a member of the expert group which authored the Radiotherapy for Lung Cancer Royal College of Radiologists Consensus Statement.

Areas of interest

Non-small cell lung cancer, small cell lung cancer, mesothelioma, thymoma, stereotactic radiotherapy, IMRT, VMAT, SBRT, immunotherapy, chemotherapy, radiotherapy, oligometastatic disease

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.